RPCF-AMR: From Resistance Surveillance to Predictive Control—A Precision Convergence Framework for Integrated Antimicrobial Resistance Governance

Reyed Precision Convergence Framework for Antimicrobial Resistance (RPCF-AMR) Antimicrobial resistance (AMR) continues to challenge existing biomedical paradigms, not only as a consequence of diminishing drug efficacy, but as a reflection of deeper systemic fragmentation across discovery, delivery, and implementation. This white paper introduces the Reyed Precision Convergence Framework for Antimicrobial Resistance (RPCF-AMR) as an integrative model designed to reframe AMR as a cross-scale coordination problem rather than a purely pharmacological limitation. The framework proposes that antimicrobial effectiveness may be more accurately understood as an emergent outcome arising from the alignment of three interdependent domains: biological response, delivery architecture, and system-level governance. By situating resistance within a broader polybiome–environment–host continuum, RPCF-AMR moves beyond reductionist models and emphasizes the distributed, context-dependent nature of antimicrobial performance. This white paper examines the structural limitations of current antimicrobial strategies, including fragmented innovation pathways, context-insensitive drug deployment, and inconsistencies in global implementation. It argues that advances in artificial intelligence, nanobiotechnology, and multi-omics, while promising, may remain insufficient unless integrated within a coordinated, system-aware framework. Through a convergence-based lens, RPCF-AMR provides a conceptual foundation for next-generation antimicrobial strategies that are predictive, adaptive, and context-responsive. The framework highlights the importance of aligning computational inference, precision delivery systems, and governance infrastructures to improve therapeutic durability and reduce resistance persistence. Looking ahead, the white paper outlines a forward-facing perspective in which antimicrobial intervention evolves from reactive containment toward adaptive system-wide management. It suggests that by 2040, convergence-based architectures may play a defining role in reshaping how resistance is understood, monitored, and controlled across clinical and environmental settings. Rather than presenting a single solution, this work offers a structured approach for integrating diverse scientific and technological advances into a coherent model of action. As such, RPCF-AMR is positioned not only as a conceptual framework, but as a strategic lens for guiding research, policy, and innovation in the evolving landscape of antimicrobial resistance.